Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig H Moskowitz

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
American Journal of Hematology|May 21, 2025
PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone LymphomaJuan Pablo Alderuccio, Russ A Kuker, Eduardo Edelman Saul, et al.
Haematologica|July 9, 2016
Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planesAnita Kumar, Irene A Burger, Zhigang Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysisLauren E Abrey, Craig H Moskowitz, Warren P Mason, et al.
Blood|January 24, 2004
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphomaTarun Kewalramani, Andrew D Zelenetz, Stephen D Nimer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2016
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell LymphomaHeiko Schöder, Andrew D Zelenetz, Paul Hamlin, et al.
Blood|September 30, 2018
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapseCraig H Moskowitz, Jan Walewski, Auayporn Nademanee, et al.
Leukemia & Lymphoma|November 30, 2017
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experienceLisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, et al.
Blood Advances|March 31, 2021
Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patientsJoachim Yahalom, Amy J Xu, Ariela Noy, et al.
Journal of Consulting and Clinical Psychology|January 26, 2011
Effectiveness of partner social support predicts enduring psychological distress after hematopoietic stem cell transplantationChristine Rini, William H Redd, Jane Austin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Paul A Hamlin, Miguel-Angel Perales, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|May 21, 2025
PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone LymphomaJuan Pablo Alderuccio, Russ A Kuker, Eduardo Edelman Saul, et al.
Haematologica|July 9, 2016
Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planesAnita Kumar, Irene A Burger, Zhigang Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysisLauren E Abrey, Craig H Moskowitz, Warren P Mason, et al.
Blood|January 24, 2004
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphomaTarun Kewalramani, Andrew D Zelenetz, Stephen D Nimer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2016
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell LymphomaHeiko Schöder, Andrew D Zelenetz, Paul Hamlin, et al.
Blood|September 30, 2018
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapseCraig H Moskowitz, Jan Walewski, Auayporn Nademanee, et al.
Leukemia & Lymphoma|November 30, 2017
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experienceLisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, et al.
Blood Advances|March 31, 2021
Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patientsJoachim Yahalom, Amy J Xu, Ariela Noy, et al.
Journal of Consulting and Clinical Psychology|January 26, 2011
Effectiveness of partner social support predicts enduring psychological distress after hematopoietic stem cell transplantationChristine Rini, William H Redd, Jane Austin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Paul A Hamlin, Miguel-Angel Perales, et al.
Pageof 15